call 1800 257 600 email [email protected]

Juvenile myelomonocytic leukaemia (JMML)

Juvenile myelomonocytic leukaemia (JMML) is a very rare type of childhood blood cancer that is caused by an overproduction of immature white blood cells (WBCs) in the blood and bone marrow. More specifically, it causes an overproduction of monocytes, which is the largest type of WBC in the blood that can develop into either a macrophage (ingest and degrade dead cells, debris, tumour cells and/or foreign substances) or a dendritic cell (initiate and regular the adaptive immune response).

Blood is the bodily fluid of the circulatory system that provides nutrients and oxygen to our tissues, and helps to remove waste from our bodies. There are three primary types of blood cells produced in the inner, spongy portion of the bone (bone marrow) from stem cells (immature blood cells that develop into either red blood cells (RBCs), white blood cells (WBCs), or platelets). RBCs, or erythrocytes, are responsible for providing oxygen to the tissues in our body, as well as transporting carbon dioxide to the lungs to be exhaled. WBCs are responsible for fighting infection and disease in the body. Platelets are blood cells that play a major role in blood clotting (or coagulation), which is an important process that helps reduce blood loss after injury.

JMML is classified as a mix of myelodysplastic syndromes (MDS) and myeloproliferative syndromes (MPN), as it shares characteristics of both. For more information on MDS or MPN, please refer to the Rare Cancers Australia Myelodysplastic Syndrome (MDS) page or the Myeloproliferative Neoplasms (MPN) page.

JMML is slightly more common in males, and tends to be diagnosed in children under four. However, anyone can develop this disease.

Treatment

When cancers are detected, they are staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, because of how rare JMMLs are, there is currently no standard staging and grading system for this disease. Instead of staging and grading, your doctor will recommend a treatment plan based on the following factors:

  • Symptoms.
  • Age.
  • General health.

Treatment preferences.

Your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. Your doctor will discuss the most appropriate course of treatment for you.

Treatment options for JMML may include:

  • Stem cell transplant.
  • Chemotherapy.
  • Clinical trials.
  • Palliative care.

Risk factors

While the cause of JMML remains unknown, some of the following factors may increase the likelihood of developing the disease:

  • Genetic mutations, potentially including:
    • NF1
    • PTPN11
    • CBL
    • RAS.
  • Having genetic conditions such as:
    • Noonan syndrome.

Not everyone with these risk factors will develop the disease, and some people who have the disease may have none of these risk factors. See your general practitioner (GP) if you are concerned.

Symptoms

JMML may appear asymptomatic during the early stages of disease. As the cancer progresses, some of the following symptoms may appear:

  • Anaemia, with symptoms potentially including:
    • Fatigue.
    • Dizziness.
    • Weakness.
    • Dyspnea.
    • Paleness.
  • Neutropenia, with symptoms potentially including:
    • Recurrent infections.
    • Fevers.
    • Mouth ulcers.
  • Thrombocytopenia, with symptoms potentially including:
    • Easy bruising.
    • Purpura or petechiae.
    • Bleeding of the nose and/or the gums.
  • Unexplained weight loss/loss of appetite.
  • Developmental delay.
  • Failure to thrive.
  • Irritability.
  • Fever.
  • Fatigue.
  • Frequent and/or persistent infections.
  • Easy bleeding and/or bruising.
  • Splenomegaly.
  • Hepatomegaly.
  • Lymphadenopathy.
  • Dyspnea.
  • Skin lesions.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have an JMML, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Blood tests.
  • Bone marrow aspiration.

References

Related Clinical Trials

See More arrow_forward

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.